| Name | Title | Type |
|---|---|---|
| Derrick Lovett | President/CEO | Auditee |
| Frank Buss II | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 365660 | 2024 | 2025-09-05 | Novogradac & Company LLP | $8.70M |
| 323017 | 2023 | 2024-09-30 | Novogradac & Company LLP | $8.70M |
| 4425 | 2022 | 2023-11-28 | Novogradac & Company LLP | $8.71M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 365660 | 2024 | 2025-09-05 | 1152096 | 2024-001 | Material Weakness | Yes | B |
| 365660 | 2024 | 2025-09-05 | 1152095 | 2024-001 | Material Weakness | Yes | B |
| 365660 | 2024 | 2025-09-05 | 575654 | 2024-001 | Material Weakness | Yes | B |
| 365660 | 2024 | 2025-09-05 | 575653 | 2024-001 | Material Weakness | Yes | B |
| 323017 | 2023 | 2024-09-30 | 1076617 | 2023-002 | Material Weakness | - | H |
| 323017 | 2023 | 2024-09-30 | 1076616 | 2023-001 | Material Weakness | Yes | B |
| 323017 | 2023 | 2024-09-30 | 1076615 | 2023-002 | Material Weakness | - | H |
| 323017 | 2023 | 2024-09-30 | 1076614 | 2023-001 | Material Weakness | Yes | B |
| 323017 | 2023 | 2024-09-30 | 500175 | 2023-002 | Material Weakness | - | H |
| 323017 | 2023 | 2024-09-30 | 500174 | 2023-001 | Material Weakness | Yes | B |
| 323017 | 2023 | 2024-09-30 | 500173 | 2023-002 | Material Weakness | - | H |
| 323017 | 2023 | 2024-09-30 | 500172 | 2023-001 | Material Weakness | Yes | B |
| 4425 | 2022 | 2023-11-28 | 579069 | 2022-003 | Significant Deficiency | Yes | N |
| 4425 | 2022 | 2023-11-28 | 579068 | 2022-002 | Significant Deficiency | - | N |
| 4425 | 2022 | 2023-11-28 | 579067 | 2022-001 | Significant Deficiency | Yes | L |
| 4425 | 2022 | 2023-11-28 | 579066 | 2022-003 | Significant Deficiency | Yes | N |
| 4425 | 2022 | 2023-11-28 | 579065 | 2022-002 | Significant Deficiency | - | N |
| 4425 | 2022 | 2023-11-28 | 579064 | 2022-001 | Significant Deficiency | Yes | L |
| 4425 | 2022 | 2023-11-28 | 2627 | 2022-003 | Significant Deficiency | Yes | N |
| 4425 | 2022 | 2023-11-28 | 2626 | 2022-002 | Significant Deficiency | - | N |
| 4425 | 2022 | 2023-11-28 | 2625 | 2022-001 | Significant Deficiency | Yes | L |
| 4425 | 2022 | 2023-11-28 | 2624 | 2022-003 | Significant Deficiency | Yes | N |
| 4425 | 2022 | 2023-11-28 | 2623 | 2022-002 | Significant Deficiency | - | N |
| 4425 | 2022 | 2023-11-28 | 2622 | 2022-001 | Significant Deficiency | Yes | L |